DE60316423D1 - Tyrosinkinase-hemmer - Google Patents
Tyrosinkinase-hemmerInfo
- Publication number
- DE60316423D1 DE60316423D1 DE60316423T DE60316423T DE60316423D1 DE 60316423 D1 DE60316423 D1 DE 60316423D1 DE 60316423 T DE60316423 T DE 60316423T DE 60316423 T DE60316423 T DE 60316423T DE 60316423 D1 DE60316423 D1 DE 60316423D1
- Authority
- DE
- Germany
- Prior art keywords
- compounds
- tyrosine kinase
- kinase inhibitor
- present
- receptor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Rheumatology (AREA)
- Endocrinology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Hematology (AREA)
- Dermatology (AREA)
- Vascular Medicine (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Transplantation (AREA)
- Ophthalmology & Optometry (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Obesity (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Urology & Nephrology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US37223202P | 2002-04-12 | 2002-04-12 | |
| US372232P | 2002-04-12 | ||
| PCT/US2003/012457 WO2003086315A2 (en) | 2002-04-12 | 2003-04-08 | Tyrosine kinase inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE60316423D1 true DE60316423D1 (de) | 2007-10-31 |
| DE60316423T2 DE60316423T2 (de) | 2008-06-12 |
Family
ID=29250816
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60316423T Expired - Lifetime DE60316423T2 (de) | 2002-04-12 | 2003-04-08 | Tyrosinkinase-hemmer |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US7371754B2 (de) |
| EP (1) | EP1496907B1 (de) |
| JP (1) | JP4475389B2 (de) |
| AT (1) | ATE373662T1 (de) |
| AU (1) | AU2003223689B2 (de) |
| CA (1) | CA2480758A1 (de) |
| DE (1) | DE60316423T2 (de) |
| ES (1) | ES2292956T3 (de) |
| WO (1) | WO2003086315A2 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60321330D1 (de) | 2002-04-12 | 2008-07-10 | Merck & Co Inc | Tyrosinkinase-hemmer |
| EP1496897A4 (de) * | 2002-04-12 | 2006-05-10 | Merck & Co Inc | Tyrosinkinase-hemmer |
| EP1993292B1 (de) | 2006-03-09 | 2013-05-15 | NEC Corporation | Verfahren und vorrichtung für dynamische bildkodierung und programm damit |
| US8530475B2 (en) | 2006-05-18 | 2013-09-10 | Janssen Pharmaceutica Nv | Bridged aryl piperazines derivatives useful for the treatment of CNS, GI-urinary and reproductive disorders |
| US8642067B2 (en) | 2007-04-02 | 2014-02-04 | Allergen, Inc. | Methods and compositions for intraocular administration to treat ocular conditions |
| CN117257805B (zh) * | 2023-11-10 | 2024-03-12 | 中山大学附属第八医院(深圳福田) | 核苷类逆转录酶抑制剂在制备抗血管钙化药物中的应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4332810A (en) | 1981-01-26 | 1982-06-01 | Merck & Co., Inc. | N-(Substituted)-2,5-ethano-8-hydroxy (or methoxy)-1,2,3,4,5,6-hexahydro-3 (or 4)-benzazocine centrally-acting analgesics |
| DK1319000T3 (da) | 2000-09-20 | 2009-02-16 | Aprea Ab | Anvendelse af 1-azabicyclo(2,2,2)oktan-3-on-derivater til behandling af cancertumorer |
| GB0110797D0 (en) * | 2001-05-02 | 2001-06-27 | Celltech R&D Ltd | Chemical compounds |
| DE60321330D1 (de) | 2002-04-12 | 2008-07-10 | Merck & Co Inc | Tyrosinkinase-hemmer |
| EP1496897A4 (de) | 2002-04-12 | 2006-05-10 | Merck & Co Inc | Tyrosinkinase-hemmer |
-
2003
- 2003-04-08 DE DE60316423T patent/DE60316423T2/de not_active Expired - Lifetime
- 2003-04-08 JP JP2003583340A patent/JP4475389B2/ja not_active Expired - Lifetime
- 2003-04-08 EP EP03719886A patent/EP1496907B1/de not_active Expired - Lifetime
- 2003-04-08 AU AU2003223689A patent/AU2003223689B2/en not_active Ceased
- 2003-04-08 US US10/510,610 patent/US7371754B2/en not_active Expired - Fee Related
- 2003-04-08 AT AT03719886T patent/ATE373662T1/de not_active IP Right Cessation
- 2003-04-08 WO PCT/US2003/012457 patent/WO2003086315A2/en not_active Ceased
- 2003-04-08 ES ES03719886T patent/ES2292956T3/es not_active Expired - Lifetime
- 2003-04-08 CA CA002480758A patent/CA2480758A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2005528387A (ja) | 2005-09-22 |
| WO2003086315A3 (en) | 2004-01-08 |
| ES2292956T3 (es) | 2008-03-16 |
| CA2480758A1 (en) | 2003-10-23 |
| EP1496907A2 (de) | 2005-01-19 |
| AU2003223689A1 (en) | 2003-10-27 |
| WO2003086315A2 (en) | 2003-10-23 |
| US20050227988A1 (en) | 2005-10-13 |
| DE60316423T2 (de) | 2008-06-12 |
| EP1496907B1 (de) | 2007-09-19 |
| AU2003223689B2 (en) | 2009-08-20 |
| US7371754B2 (en) | 2008-05-13 |
| JP4475389B2 (ja) | 2010-06-09 |
| ATE373662T1 (de) | 2007-10-15 |
| EP1496907A4 (de) | 2006-05-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE482938T1 (de) | Tyrosinkinaseinhibitoren | |
| WO2004014300A3 (en) | Tyrosine kinase inhibitors | |
| WO2003035615A3 (en) | Tyrosine kinase inhibitors | |
| DK1362047T3 (da) | Indazolylsubstituerede pyrrolinforbindelser som kinaseinhibitorer | |
| WO2004031401A3 (en) | Novel tyrosine kinases inhibitors | |
| AU2001241798A1 (en) | 3-(pyrolyllactone)-2-indolinone compounds as kinase inhibitors | |
| WO2004096795A3 (en) | C-fms kinase inhibitors | |
| WO2003035616A3 (en) | Tyrosine kinase inhibitors | |
| CA2400447A1 (en) | Kinase inhibitors | |
| WO2003035619A8 (en) | Tyrosine kinase inhibitors | |
| SG132683A1 (en) | Imidazopyrazine tyrosine kinase inhibitors | |
| PL361404A1 (en) | Synergistic combinations comprising a renin inhibitor for cardiovascular diseases | |
| WO2001019828A3 (en) | Kinase inhibitors as therapeutic agents | |
| IL163781A0 (en) | Purine derivatives as kinase inhibitors | |
| MY139689A (en) | Imidazotriazines as protein kinase inhibitors | |
| WO2003035614A3 (en) | Tyrosine kinase inhibitors | |
| IL163777A0 (en) | Kinase inhibitors | |
| WO2006047479A3 (en) | C-fms kinase inhibitors | |
| MXPA05013076A (es) | Compuestos de isoindolina-1-ona como inhibidores de cinasa. | |
| WO2006047503A3 (en) | Inhibitors of c-fms kinase | |
| AU2001230395A1 (en) | Use of cox-2 inhibitors as gastroprokinetics | |
| DE60316423D1 (de) | Tyrosinkinase-hemmer | |
| TW200628153A (en) | Novel compounds | |
| DE60321330D1 (de) | Tyrosinkinase-hemmer | |
| WO2005009373A3 (en) | Tyrosine kinase inhibitors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8327 | Change in the person/name/address of the patent owner |
Owner name: MERCK SHARP & DOHME CORP., RAHWAY, N.J., US |
|
| 8328 | Change in the person/name/address of the agent |
Representative=s name: MARKS & CLERK (LUXEMBOURG) LLP, LUXEMBOURG, LU |